Strength and Strength-ratio of Hip Rotator Muscles at Soccer Players

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At this investigation we want to find out whether there is a difference in muscle strength of the internal and external rotation hip muscles between soccer players and non-soccer players caused by typical movement patterns seen in soccer sport.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nontraumatic hip injuries are a problem often seen in Soccer Players. A biomechanical formation mechanism is probably. Little research has focused on the measurement of hip external and internal rotation strength at soccer players. The purpose of this study is to investigate the influence of soccer sports at the isometric force and force ratio of the hip rotator muscle system. Two samples of Athletes will be compared: Soccer Players (N15) and Non-soccer players (N15) matched in sex, age and level of physical activity to investigate hip rotator force in 3 different angles of hip flexion (0°/45°/90°). The measurement will be made with a handheld dynamometer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Injuries Muscular Atrophy Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hip rotators muscle strength

No interventions assigned to this group

control group

no intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Study group:

Amateur footballers (N15) in the age between 18 and 35 At least five years of active footballer's career Football training twice weekly Active participation in play No pain or limitations in the area of the hip or the lower extremity

Control group:

Athletes (N15), non-soccer players with now asymmetric leg activities In the age between 18 and 35 At least twice weekly sports activity for at least 30 minutes No pain or limitations in the area of the hip or the lower extremity

Exclusion Criteria

Professions with asymmetric leg activities Pain or limitations in the area of the hip or the lower extremity Surgery on the hip in the prehistory

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Niklaus F. Friederich, MD Professor

Role: PRINCIPAL_INVESTIGATOR

Head of degree program: Master of Functional Kinetic Science, University of Basel, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Physiotherapy Burch&Keiser

Sarnen, Canton of Obwalden, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

c.b.1.1

Identifier Type: -

Identifier Source: org_study_id